Watch Ticker

Opthea Limited American Depositary Shares

Go to Opthea Limited American Depositary Shares Website

$3.41

(%)

Live

Previous Close

$3.41

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$ USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Opthea to Present at Oppenheimer Healthcare Conference

Opthea, a clinical-stage biopharmaceutical company, announced that its CEO will present at the Oppenheimer Healthcare Life Sciences Conference. The company is developing a novel therapy, sozinibercept, for the treatment of wet age-related macular degeneration.

Related tickers: OPT.

Read Full Article

N/A - Opthea Appoints Kathy Connell to Board of Directors

Opthea, a clinical-stage biopharmaceutical company, has appointed Kathy Connell, a commercial executive with business development expertise, to its Board of Directors. The appointment comes as Opthea prepares for the Phase 3 topline data readout of its wet AMD treatment, sozinibercept, in 2025.

Related tickers: OPT.

Read Full Article

Trending Tickers

Please sign in to view